Co-Authors
This is a "connection" page, showing publications co-authored by Roberto Cauda and Francesco Landi.
Connection Strength
0.223
-
Sarilumab use in severe SARS-CoV-2 pneumonia. EClinicalMedicine. 2020 Oct; 27:100553.
Score: 0.057
-
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
Score: 0.056
-
Off-label use of tocilizumab in patients with SARS-CoV-2 infection. J Med Virol. 2020 10; 92(10):1787-1788.
Score: 0.056
-
Challenges in COVID-19: is pulmonary thromboembolism related to overall severity? Infect Dis (Lond). 2020 08; 52(8):585-589.
Score: 0.055